Cryptococcal meningitis is an uncommon and severe infection that tends to affect
immunocompromised hosts worldwide and in the United States. Annually it is estimated that …

Introduction Survival among people with HIV-associated cryptococcal meningitis (CM)
remains low, particularly among women, despite the currently optimal use of antifungal …

Background Increased antiretroviral therapy (ART) availability has been associated with
more patients developing cryptococcosis after ART initiation. Despite this changing …

Background The impact of the “test and treat” program for human immunodeficiency virus
(HIV) treatment in rural areas of Uganda on cryptococcal antigen (CrAg) screening or …

Background Cryptococcal meningitis and tuberculosis are both important causes of death in
persons with advanced human immunodeficiency virus (HIV)/acquired immunodeficiency …

Background Cryptococcal meningitis (CM) remains a leading cause of death in HIV-infected
patients, despite advances in CM diagnostic and therapeutic strategies. This study was …

Abstract Background Idiopathic CD4+ T lymphocytopenia (ICL) is a rare immunodeficiency
syndrome, unaccompanied by various opportunistic infections. Cryptococcus and varicella …

Objectives CMV viremia is associated with increased mortality in persons with HIV. We
previously demonstrated that CMV viremia was a risk factor for 10-week mortality in …

Existing evidence revealed grave prognosis for cryptococcal meningitis (CM), particularly its
short-term mortality. However, its long-term survival and prognostic factors remained …

Background Cryptococcal meningitis (CM) is the most common fungal infection of the central
nervous system that can cause significant morbidity and mortality. Although several …